NUWE · Nuwellis, Inc.
$2.85
-0.09 (-3.06%)
At close · Jul 17
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, including continued operating losses, negative cash flows from operations, an accumulated deficit of $320.9 million, and the need for additional capital to fund ongoing operations and growth initiatives (including the integration of the Rendiatech acquisition), raise substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these financial statements are issued. While management’s plans, including recent financing activities, cost discipline initiatives, and contingency measures, are intended to address these conditions, such plans do not alleviate the substantial doubt.”View the 10-Q filed May 15, 2026
Market Cap
$7.64M
Shares
2,680,752
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.27M
-5.4%
FY2025
Net Income
-$17.52M
-56.9%
FY2025
Gross Margin
61.96%
-3pp
FY2025
Operating Margin
-134.29%
-8.6pp
FY2025
Diluted EPS
-$888.65
+92.8%
FY2025
Operating Cash Flow
-$10.81M
-12.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $8.77M | $8.27M | $8.74M | $8.86M | $8.54M | $7.92M | $7.44M | $5.51M | $5M | $3.55M | $1.29M | $59K | $295K | $59K | $0 | — | |
| $3.03M | $3.15M | $3.06M | $3.88M | $3.79M | $3.43M | $3.38M | $2.66M | $3.67M | $2.76M | $713K | — | — | — | — | — | |
| $5.74M | $5.12M | $5.68M | $4.98M | $4.76M | $4.49M | $4.06M | — | — | — | — | — | — | — | — | — | |
| — | 61.96% | 64.94% | 56.22% | 55.66% | 56.7% | 54.52% | — | — | — | — | — | — | — | — | — | |
| $3.89M | $2.71M | $3.21M | $5.42M | $4.34M | $4.98M | $3.67M | $4.67M | $3.05M | $1.48M | $8.11M | $17.67M | $16.87M | $13.5M | $8M | $11.2M | |
| $14.47M | $13.52M | $13.46M | $17.19M | $17.58M | $19.04M | $17.42M | $16.29M | $15.31M | $10.17M | $8.13M | $8.35M | $9.21M | $9.43M | $6.87M | $5.36M | |
| — | — | — | — | — | — | — | — | $0 | $540K | $278K | $0 | — | — | — | — | |
| — | $200K | $310K | $362K | $372K | $488K | $376K | $239K | $232K | $769K | $697K | $325K | $277K | $185K | $138K | $50K | |
| $18.36M | $16.23M | $16.66M | $22.61M | $21.93M | $24.02M | $21.09M | — | $22.03M | $18.37M | $16.95M | $26.02M | $26.08M | $22.93M | $14.87M | $16.56M | |
| — | — | — | — | — | — | $24.47M | $23.62M | $22.03M | — | — | — | — | — | — | — | |
| -$12.61M | -$11.11M | -$10.99M | -$17.63M | -$17.17M | -$19.53M | -$17.03M | -$18.11M | -$17.04M | -$14.81M | -$15.66M | -$25.96M | -$25.79M | -$22.87M | -$14.87M | -$16.56M | |
| — | -134.29% | -125.72% | -198.89% | -200.99% | -246.51% | -228.84% | -328.54% | -340.86% | -416.89% | -1215.05% | -43996.61% | -8741.36% | -38764.41% | — | — | |
| — | -$10.91M | -$10.68M | -$17.27M | -$16.8M | -$19.04M | -$16.65M | -$17.87M | -$16.8M | -$14.04M | -$14.97M | -$25.63M | -$25.51M | -$22.69M | -$14.73M | -$16.51M | |
| — | — | — | — | — | — | — | — | — | — | $504K | $743K | — | — | — | — | |
| $12K | — | — | — | — | — | — | — | — | — | — | — | — | — | $33K | $251K | |
| $4000 | $10K | -$80K | $154K | $75K | -$19K | -$1000 | $0 | $10K | $1.44M | $2000 | -$6000 | -$49K | -$100K | $33K | — | |
| -$19.04M | -$17.52M | -$11.16M | -$20.2M | -$14.52M | -$19.55M | -$15.83M | -$18.11M | -$17.03M | -$13.38M | -$15.85M | -$26.71M | -$25.84M | -$22.97M | -$14.84M | -$16.31M | |
| $4000 | $5000 | $5000 | $8000 | $9000 | $9000 | $9000 | $8000 | $6000 | $6000 | -$54K | -$124K | -$249K | -$1.21M | -$771K | -$115K | |
| -$19.05M | -$17.52M | -$11.17M | -$20.21M | -$14.53M | -$19.55M | -$15.84M | -$18.11M | -$17.03M | -$13.38M | -$15.79M | — | — | — | — | — | |
| — | -211.86% | -127.75% | -227.99% | -170.02% | -246.86% | -212.82% | -328.69% | -340.78% | -376.64% | -1225.14% | — | — | — | — | — | |
| -$19.04M | -$17.52M | -$10.62M | -$22.63M | -$14.53M | -$19.62M | -$17.59M | -$22.62M | -$17.03M | -$24.97M | -$17.69M | -$26.58M | -$25.59M | -$21.76M | -$14.07M | -$16.2M | |
| -$18.99M | -$17.47M | -$11.18M | -$20.28M | -$14.45M | -$19.58M | -$17.06M | -$18.12M | -$17.04M | -$13.39M | -$15.8M | -$26.61M | -$25.52M | -$21.74M | -$14.01M | -$16.06M | |
| USD/shares | — | -$888.65 | -$12,365.50 | -$529,288.20 | -$4,298,647.50 | -$14,681,772.00 | -$54,897,150.00 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$888.65 | -$12,365.50 | -$529,288.20 | -$4,298,647.50 | -$14,681,772.00 | -$54,897,150.00 | — | — | — | — | — | — | — | — | — |
| shares | — | 19.72K | 902.8857 | 38.181 | 3.3789 | 1.3411 | 0.3205 | 0.0157 | 0.0026 | 0.0003 | 0.0002 | 0.0039 | 0.1095 | 0.0824 | 0.046 | 0.0353 |
| shares | — | 19.72K | 902.8857 | 38.181 | 3.3789 | 1.3411 | 0.3205 | 0.0157 | 0.0026 | 0.0003 | 0.0002 | 0.0039 | 0.1095 | 0.0824 | 0.046 | 0.0353 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.19×
EV/EBIT
—
Medical Devices median 21.50×
P/E (TTM)
0.06×
Medical Devices median 27.84×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Fluid Overload | $8,270,000 | $8,740,000 | $8,864,000 |